298 related articles for article (PubMed ID: 22209487)
1. Design, synthesis, and structure-activity relationship studies of conformationally restricted mutilin 14-carbamates.
Fu L; Liu X; Ling C; Cheng J; Guo X; He H; Ding S; Yang Y
Bioorg Med Chem Lett; 2012 Jan; 22(2):814-9. PubMed ID: 22209487
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro antibacterial activity of 7-(3-alkoxyimino-5-amino/methylaminopiperidin-1-yl)fluoroquinolone derivatives.
Zhang Y; Li G; Liu M; You X; Feng L; Lv K; Cao J; Guo H
Bioorg Med Chem Lett; 2011 Feb; 21(3):928-31. PubMed ID: 21232952
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antibacterial activity of novel 4''-carbamates of 6,11-di-O-methylerythromycin A.
Wu Z; Lu Y; Luo M; He X; Xiao Y; Yang J; Pan Y; Qiu G; Xu Y; Huang W; Long P; Li R; Hu X
J Antibiot (Tokyo); 2010 Jul; 63(7):343-50. PubMed ID: 20448668
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antibacterial activity of novel modified 5-O-desosamine ketolides.
Chen X; Xu P; Xu Y; Liu L; Liu Y; Zhu D; Lei P
Bioorg Med Chem Lett; 2012 Dec; 22(24):7402-5. PubMed ID: 23122862
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro antibacterial activity of 7-(3-alkoxyimino-4-amino-4-methylpiperidin-1-yl) fluoroquinolone derivatives.
Wang JX; Zhang YB; Liu ML; Wang B; Chai Y; Li SJ; Guo HY
Eur J Med Chem; 2011 Jun; 46(6):2421-6. PubMed ID: 21481984
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and potent antimicrobial activity of some novel 4-(5, 6-dichloro-1H-benzimidazol-2-yl)-N-substituted benzamides.
Ozden S; Karataş H; Yildiz S; Göker H
Arch Pharm (Weinheim); 2004 Oct; 337(10):556-62. PubMed ID: 15476288
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and SAR study of novel 7-(pyridinium-3-yl)-carbonyl imidazo[5,1-b]thiazol-2-yl carbapenems.
Maruyama T; Kano Y; Yamamoto Y; Kurazono M; Iwamatsu K; Atsumi K; Shitara E
Bioorg Med Chem; 2007 Jan; 15(1):392-402. PubMed ID: 17055731
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antibacterial activity of new 4″-O-carbamates of 11,12-cyclic carbonate erythromycin A 6,9-imino ether.
Zhang L; Jiao B; Yang X; Liu L; Ma S
J Antibiot (Tokyo); 2011 Mar; 64(3):243-7. PubMed ID: 21245870
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in-vitro antibacterial activity of 7-(3-aminopyrrolo[3,4-c]pyrazol-5(2H,4H,6H)-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivatives.
Guo X; Bai XG; Li YL; An ZJ; Xu LX; Han LY; Liu ML; Guo HY; Wang YC
Arch Pharm (Weinheim); 2011 Aug; 344(8):523-9. PubMed ID: 21656543
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antibacterial activity of novel 11,12-cyclic carbonate azithromycin 4''-O-carbamate derivatives.
Ma C; Liu Z; Song H; Jiang R; He F; Ma S
J Antibiot (Tokyo); 2010 Jan; 63(1):3-8. PubMed ID: 19911029
[TBL] [Abstract][Full Text] [Related]
11. Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analogues.
Elliott RL; Pireh D; Griesgraber G; Nilius AM; Ewing PJ; Bui MH; Raney PM; Flamm RK; Kim K; Henry RF; Chu DT; Plattner JJ; Or YS
J Med Chem; 1998 May; 41(10):1651-9. PubMed ID: 9572890
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
Chen YH; Liu CY; Lu JJ; King CH; Hsueh PR
J Antimicrob Chemother; 2009 Dec; 64(6):1226-9. PubMed ID: 19833635
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and antibacterial activities of novel 3,6-bicyclolide oximes: length optimization and zero carbon linker oximes.
Tang D; Gai Y; Polemeropoulos A; Chen Z; Wang Z; Or YS
Bioorg Med Chem Lett; 2008 Sep; 18(18):5078-82. PubMed ID: 18762418
[TBL] [Abstract][Full Text] [Related]
14. Phenazine antibiotic inspired discovery of potent bromophenazine antibacterial agents against Staphylococcus aureus and Staphylococcus epidermidis.
Borrero NV; Bai F; Perez C; Duong BQ; Rocca JR; Jin S; Huigens RW
Org Biomol Chem; 2014 Feb; 12(6):881-6. PubMed ID: 24389824
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of diverse analogues of Oenostacin and their antibacterial activities.
Srivastava V; Darokar MP; Fatima A; Kumar JK; Chowdhury C; Saxena HO; Dwivedi GR; Shrivastava K; Gupta V; Chattopadhyay SK; Luqman S; Gupta MM; Negi AS; Khanuja SP
Bioorg Med Chem; 2007 Jan; 15(1):518-25. PubMed ID: 17035037
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antibacterial evaluation of rhodanine-based 5-aryloxy pyrazoles against selected methicillin resistant and quinolone-resistant Staphylococcus aureus (MRSA and QRSA).
Song MX; Zheng CJ; Deng XQ; Sun LP; Wu Y; Hong L; Li YJ; Liu Y; Wei ZY; Jin MJ; Piao HR
Eur J Med Chem; 2013 Feb; 60():376-85. PubMed ID: 23314051
[TBL] [Abstract][Full Text] [Related]
17. Exploration of (3-benzyl-5-hydroxyphenyl)carbamates as new antibacterial agents against Gram-positive bacteria.
Liang HJ; Cheng YJ; Wang LX; Huang BQ; Zhang NN; Liang J; Yan M
Arch Pharm (Weinheim); 2020 Mar; 353(3):e1900294. PubMed ID: 31894862
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and in vitro antibacterial activity of fluoroquinolone derivatives containing a chiral 3-(alkoxyimino)-2-(aminomethyl)azetidine moiety.
Lv K; Sun Y; Sun L; Wei Z; Guo H; Wu J; Liu M
ChemMedChem; 2012 Jul; 7(7):1230-6. PubMed ID: 22639240
[TBL] [Abstract][Full Text] [Related]
19. Novel pleuromutilin derivatives as antibacterial agents: synthesis, biological evaluation and molecular docking studies.
Wang X; Ling Y; Wang H; Yu J; Tang J; Zheng H; Zhao X; Wang D; Chen G; Qiu W; Tao J
Bioorg Med Chem Lett; 2012 Oct; 22(19):6166-72. PubMed ID: 22932314
[TBL] [Abstract][Full Text] [Related]
20. [Synthesis and antibacterial activity of 3-hydroxy-6-O-methylerythromycin-9-O-substituted oxime derivatives].
Chen SX; Xu XD; Yu LX
Yao Xue Xue Bao; 2001 Aug; 36(8):581-4. PubMed ID: 12579933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]